MedTrace Logo

Intraperitoneal Tramadol Versus Dexmedetomedine for Analgesia After Abdominal Laparoscopic Cancer Surgeries

NCT04813016 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-06-02

No results posted yet for this study

Summary

Multiple modalities for postoperative analgesia after laparoscopic procedures has been used, of them intraperitoneal route (IP) was used to decrease the analgesic requirements. Both early and late bupivacaine and tramadol versus bupivacaine and dexmedetomedine will be tried to choose which is having a better analgesic profile.

Conditions

  • Analgesia

Interventions

DRUG

Tramal 1

Early intraperitoneal injection of tramal and bupivacaine

DRUG

Tramal 2

Late intraperitoneal injection of tramal and bupivacaine

DRUG

Dexmedetomidine 1

Early intraperitoneal injection of dexmedetomidine and bupivacaine

DRUG

dexmedetomidine 2

Late intraperitoneal injection of dexmedetomedine and bupivacaine

Sponsors & Collaborators

  • National Cancer Institute, Egypt

    lead OTHER

Principal Investigators

  • Ehab H Gendy, MD · Assistant Professor of Anesthesia, intensive care and pain releif

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2022-04-30
Completion
2022-05-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04813016 on ClinicalTrials.gov